Translation:
Care health services to the global situation Coronavirus infections
Middle East Respiratory Syndrome (MERS-CoV)
June 2013
PREVENTIVE CARE NOTICE PORMERS-COV
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV), formerly known as "New
coronavirus (nCoV) ", was identified in September 2012 in Saudi Arabia. So far, the Organization
World Health Organization (WHO) has been informed of a total of 54 laboratory-confirmed cases of infection
MERS human-CoV, including 30 deaths (CFR 55.5%) globally.
WHO has issued a document with recommendations for monitoring human infection MERSCoV, which highlights so far has reported limited transmission from human to human,
documenting with secondary cases in the UK, France, Saudi Arabia, Tunisia and Italy. They have been affected
by this human transmission, the closest contacts: health workers, family and other patients
who shared room with confirmed cases. The mode of transmission and the source of exposure continue
remain unknown and are under investigation.
It has been established that all confirmed cases presented respiratory infection, major complications
include severe pneumonia with respiratory failure requiring ventilatory support, respiratory distress syndrome
(ARDS) with multiple organ failure, renal failure, coagulopathy, and pericarditis.
According to WHO, will be considered a research patient under those with acute respiratory infection
comply with the following:
• Fever greater than or equal to 38 ° C and cough,
• Suspected parenchymal lung disease (pneumonia or acute respiratory distress syndrome in
based on clinical or radiological evidence of consolidation),
• History of travel to the Arabian Peninsula and neighboring countries in the past 10 days (Bahrain, Iraq, Iran,
Israel, Jordan, Kuwait, Lebanon, Oman, State of Palestine, Qatar, Saudi Arabia, Syria, United Arab
Emirates and Yemen),
• Respiratory infection not explained by another infection or etiology and laboratory tests including
relevant to community-acquired pneumonia, which is discarded: influenza A and B Syncytial Virus
Respiratory, Streptococcus pneumoniae, and Legionella pneumophila.
It will be considered a probable case that it has the following criteria:
• People with the definition of patient under investigation that have no possibility of confirmation
through laboratory, either because the patient or samples are not available, or because you can
Laboratory tests rule out other respiratory infections
• Close contact with a laboratory-confirmed case,
• Respiratory infection not explained by infection or other etiology.
http://www.epidemiologia.salud.gob.mx/doctos/alertas/2013/APA_MERSCoV_060613_1.pdf
No comments:
Post a Comment